Overseas patent risks and litigation costs might impact Chinese firms seeking public listing on the high tech board of the Shanghai Stock Exchange. BGI is not the first Chinese tech company whose patent expenses have come under great scrutiny.
26 Mar
2021
Filings show Chinese gene sequencer BGI has paid out millions in legal fees battling Illumina over patents
